JP2004509955A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004509955A5 JP2004509955A5 JP2002531111A JP2002531111A JP2004509955A5 JP 2004509955 A5 JP2004509955 A5 JP 2004509955A5 JP 2002531111 A JP2002531111 A JP 2002531111A JP 2002531111 A JP2002531111 A JP 2002531111A JP 2004509955 A5 JP2004509955 A5 JP 2004509955A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- carbon atoms
- pharmaceutically acceptable
- compound
- acceptable base
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 description 190
- 125000004432 carbon atom Chemical group C* 0.000 description 189
- 150000001875 compounds Chemical class 0.000 description 80
- 150000001768 cations Chemical class 0.000 description 64
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 28
- 102100039282 Cytochrome P450 26A1 Human genes 0.000 description 24
- 101710130818 Cytochrome P450 26A1 Proteins 0.000 description 24
- 102000004190 Enzymes Human genes 0.000 description 24
- 108090000790 Enzymes Proteins 0.000 description 24
- 241000124008 Mammalia Species 0.000 description 23
- 229910052801 chlorine Inorganic materials 0.000 description 23
- 230000002401 inhibitory effect Effects 0.000 description 23
- 229910052740 iodine Inorganic materials 0.000 description 23
- 239000008194 pharmaceutical composition Substances 0.000 description 23
- 229910052794 bromium Inorganic materials 0.000 description 22
- 239000000203 mixture Substances 0.000 description 21
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 20
- 229910052731 fluorine Inorganic materials 0.000 description 19
- 125000001072 heteroaryl group Chemical group 0.000 description 19
- -1 1-imidazolyl Chemical group 0.000 description 18
- 125000000753 cycloalkyl group Chemical group 0.000 description 17
- 125000004414 alkyl thio group Chemical group 0.000 description 16
- 150000003839 salts Chemical class 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 12
- 125000003545 alkoxy group Chemical group 0.000 description 12
- 229910052736 halogen Chemical group 0.000 description 12
- 125000001624 naphthyl group Chemical group 0.000 description 10
- 125000002541 furyl group Chemical group 0.000 description 9
- 125000002883 imidazolyl group Chemical group 0.000 description 9
- 125000002971 oxazolyl group Chemical group 0.000 description 9
- 125000003373 pyrazinyl group Chemical group 0.000 description 9
- 125000003226 pyrazolyl group Chemical group 0.000 description 9
- 125000002098 pyridazinyl group Chemical group 0.000 description 9
- 125000004076 pyridyl group Chemical group 0.000 description 9
- 125000000714 pyrimidinyl group Chemical group 0.000 description 9
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 9
- 125000000335 thiazolyl group Chemical group 0.000 description 9
- 125000001544 thienyl group Chemical group 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 6
- 125000005843 halogen group Chemical group 0.000 description 6
- 150000002367 halogens Chemical class 0.000 description 6
- 229910052717 sulfur Inorganic materials 0.000 description 5
- 230000002194 synthesizing effect Effects 0.000 description 4
- 239000005711 Benzoic acid Substances 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- LNETULKMXZVUST-UHFFFAOYSA-N 1-naphthoic acid Chemical compound C1=CC=C2C(C(=O)O)=CC=CC2=C1 LNETULKMXZVUST-UHFFFAOYSA-N 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 150000001733 carboxylic acid esters Chemical group 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 0 *CC1C#CC(O)=CC1 Chemical compound *CC1C#CC(O)=CC1 0.000 description 1
- XMNHGDPCBNIWFV-UHFFFAOYSA-N 2-[2-fluoro-4-[2-(2,2,4,4-tetramethyl-3h-chromen-6-yl)ethynyl]phenyl]acetic acid Chemical compound C=1C=C2OC(C)(C)CC(C)(C)C2=CC=1C#CC1=CC=C(CC(O)=O)C(F)=C1 XMNHGDPCBNIWFV-UHFFFAOYSA-N 0.000 description 1
- JBKIUXYXZUSWPS-UHFFFAOYSA-N 2-[4-(8,8-dimethyl-5-oxo-6,7-dihydronaphthalene-2-carbonyl)oxyphenyl]acetic acid Chemical compound C1=C2C(C)(C)CCC(=O)C2=CC=C1C(=O)OC1=CC=C(CC(O)=O)C=C1 JBKIUXYXZUSWPS-UHFFFAOYSA-N 0.000 description 1
- ITXFQVKXIVKNHH-UHFFFAOYSA-N 2-[4-[2-(2,2,4,4-tetramethyl-3h-chromen-6-yl)ethynyl]phenyl]acetic acid Chemical compound C=1C=C2OC(C)(C)CC(C)(C)C2=CC=1C#CC1=CC=C(CC(O)=O)C=C1 ITXFQVKXIVKNHH-UHFFFAOYSA-N 0.000 description 1
- DGFTWCCCWFYBFB-UHFFFAOYSA-N 2-[4-[2-(5-imidazol-1-yl-8,8-dimethyl-6,7-dihydro-5h-naphthalen-2-yl)ethynyl]phenyl]acetic acid Chemical compound C1=C2C(C)(C)CCC(N3C=NC=C3)C2=CC=C1C#CC1=CC=C(CC(O)=O)C=C1 DGFTWCCCWFYBFB-UHFFFAOYSA-N 0.000 description 1
- LWCBOTGILHXRHK-UHFFFAOYSA-N 2-[4-[2-(8,8-dimethyl-5-oxo-6,7-dihydronaphthalen-2-yl)ethynyl]-2-fluorophenyl]acetic acid Chemical compound C1=C2C(C)(C)CCC(=O)C2=CC=C1C#CC1=CC=C(CC(O)=O)C(F)=C1 LWCBOTGILHXRHK-UHFFFAOYSA-N 0.000 description 1
- LYOAHZUZZNMLNC-UHFFFAOYSA-N 2-[4-[2-(8-cyclopropyl-2,2,4,4-tetramethyl-3h-chromen-6-yl)ethynyl]-2-fluorophenyl]acetic acid Chemical compound C=12OC(C)(C)CC(C)(C)C2=CC(C#CC=2C=C(F)C(CC(O)=O)=CC=2)=CC=1C1CC1 LYOAHZUZZNMLNC-UHFFFAOYSA-N 0.000 description 1
- FKURZNWAFOUMKK-UHFFFAOYSA-N 2-[4-[2-(8-cyclopropyl-2,2,4,4-tetramethyl-3h-chromen-6-yl)ethynyl]phenyl]acetic acid Chemical compound C=12OC(C)(C)CC(C)(C)C2=CC(C#CC=2C=CC(CC(O)=O)=CC=2)=CC=1C1CC1 FKURZNWAFOUMKK-UHFFFAOYSA-N 0.000 description 1
- UBXQMNPDZOGDSY-UHFFFAOYSA-N 2-[4-[2-(8-ethyl-2,2,4,4-tetramethyl-3h-chromen-6-yl)ethynyl]phenyl]acetic acid Chemical compound C=1C(C(CC(C)(C)O2)(C)C)=C2C(CC)=CC=1C#CC1=CC=C(CC(O)=O)C=C1 UBXQMNPDZOGDSY-UHFFFAOYSA-N 0.000 description 1
- WNJLJQKQEKVIJT-UHFFFAOYSA-N 2-fluoro-4-[2-(2,2,4,4-tetramethyl-3h-chromen-6-yl)ethynyl]benzoic acid Chemical compound C=1C=C2OC(C)(C)CC(C)(C)C2=CC=1C#CC1=CC=C(C(O)=O)C(F)=C1 WNJLJQKQEKVIJT-UHFFFAOYSA-N 0.000 description 1
- VSHLPGYGJSORKV-UHFFFAOYSA-N 4-[2-(8,8-dimethyl-5-oxo-6,7-dihydronaphthalen-2-yl)ethynyl]-2-fluorobenzoic acid Chemical compound C1=C2C(C)(C)CCC(=O)C2=CC=C1C#CC1=CC=C(C(O)=O)C(F)=C1 VSHLPGYGJSORKV-UHFFFAOYSA-N 0.000 description 1
- QELVCKRITXHFTQ-UHFFFAOYSA-N 4-[2-(8-cyclopropyl-2,2,4,4-tetramethyl-3h-chromen-6-yl)ethynyl]benzoic acid Chemical compound C=12OC(C)(C)CC(C)(C)C2=CC(C#CC=2C=CC(=CC=2)C(O)=O)=CC=1C1CC1 QELVCKRITXHFTQ-UHFFFAOYSA-N 0.000 description 1
- CVJNXBWYODEEOO-UHFFFAOYSA-N 4-[2-[5-[cyclopropyl(methyl)amino]-8,8-dimethyl-6,7-dihydro-5h-naphthalen-2-yl]ethynyl]-2-fluorobenzoic acid Chemical compound C1CC(C)(C)C2=CC(C#CC=3C=C(F)C(C(O)=O)=CC=3)=CC=C2C1N(C)C1CC1 CVJNXBWYODEEOO-UHFFFAOYSA-N 0.000 description 1
- 238000006218 Arndt-Eistert homologation reaction Methods 0.000 description 1
- XJTOPAXEUDXMNT-UHFFFAOYSA-N COC(CC1C(F)=CC(I)=CC1)=O Chemical compound COC(CC1C(F)=CC(I)=CC1)=O XJTOPAXEUDXMNT-UHFFFAOYSA-N 0.000 description 1
- IYIVBGQBEMSRLO-UHFFFAOYSA-N COC(Cc(cc1)ccc1I)=O Chemical compound COC(Cc(cc1)ccc1I)=O IYIVBGQBEMSRLO-UHFFFAOYSA-N 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000011905 homologation Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/672,751 US6313107B1 (en) | 2000-08-29 | 2000-09-28 | Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| PCT/US2001/025465 WO2002026727A2 (en) | 2000-09-28 | 2001-08-14 | Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004509955A JP2004509955A (ja) | 2004-04-02 |
| JP2004509955A5 true JP2004509955A5 (OSRAM) | 2008-11-20 |
Family
ID=24699854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002531111A Pending JP2004509955A (ja) | 2000-09-28 | 2001-08-14 | シトクロムｐ４５０ｒａｉ阻害剤としての活性を有する化合物（レチノイド）を提供および使用する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US6313107B1 (OSRAM) |
| EP (1) | EP1322631A2 (OSRAM) |
| JP (1) | JP2004509955A (OSRAM) |
| AU (2) | AU8647801A (OSRAM) |
| CA (1) | CA2423919A1 (OSRAM) |
| WO (1) | WO2002026727A2 (OSRAM) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1642885B1 (en) | 2000-08-29 | 2009-11-11 | Biocon Limited | Use of a pharmaceutical composition containing a para-aminophenyl acetic acid derivative for treating inflammatory conditions of the gastrointestinal tract |
| US6313107B1 (en) * | 2000-08-29 | 2001-11-06 | Allergan Sales, Inc. | Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| US8048924B2 (en) | 2001-08-29 | 2011-11-01 | Biocon Limited | Methods and compositions employing 4-aminophenylacetic acid compounds |
| AU2002351412B2 (en) | 2001-12-21 | 2010-05-20 | Exelixis Patent Company Llc | Modulators of LXR |
| US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
| US6740676B2 (en) * | 2002-03-19 | 2004-05-25 | Allergan, Inc. | 4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-benzoic and 2-[4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-phenyl]-acetic acid, their esters and salts having cytochrome p450rai inhibitory activity |
| US20090181966A1 (en) * | 2002-10-04 | 2009-07-16 | Millennium Pharmaceuticals, Inc. | PGD2 receptor antagonists for the treatment of inflammatory diseases |
| US7504508B2 (en) * | 2002-10-04 | 2009-03-17 | Millennium Pharmaceuticals, Inc. | PGD2 receptor antagonists for the treatment of inflammatory diseases |
| PL376156A1 (en) * | 2002-10-04 | 2005-12-27 | Millennium Pharmaceuticals, Inc. | Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| GB0302094D0 (en) | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| US6683092B1 (en) | 2003-04-09 | 2004-01-27 | Allergan, Inc. | [3-(c5-14alkyl-2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-3-oxo-propenyl]-phenyl and [3-(c5-14alkyl-2-oxo-1,2,3,4- tetrahydro-quinolin-6-yl)-3-oxo-propenyl]-heteroaryl derivatives having anti-tumor activity |
| US6734193B1 (en) | 2003-06-03 | 2004-05-11 | Allergan, Inc. | (1,2,3,4-tetrahydroquinolin-8-yl)-heptatrienoic acid derivatives having serum glucose reducing activity |
| GB0324269D0 (en) | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| US7226951B2 (en) * | 2003-12-17 | 2007-06-05 | Allergan, Inc. | Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same |
| CA2550010A1 (en) | 2003-12-17 | 2005-06-30 | Allergan, Inc. | Methods for treating retinoid responsive disorders using selective inhibitors of cyp26a and cyp26b |
| US8198329B2 (en) | 2004-03-10 | 2012-06-12 | Research Foundation Itsuu Laboratory | Memory consolidation promoting agent and method of use |
| HUE028158T2 (en) | 2004-07-07 | 2016-12-28 | Biocon Ltd | Synthesis of bound immunoregulatory compounds |
| US7576094B2 (en) * | 2004-12-13 | 2009-08-18 | Eli Lilly And Company | Spiro derivatives as lipoxygenase inhibitors |
| BRPI0608553A2 (pt) * | 2005-02-24 | 2010-01-12 | Millennium Pharm Inc | antagonistas de receptor de pgd2 para o tratamento de doenças inflamatórias |
| US7811261B2 (en) | 2008-06-02 | 2010-10-12 | Sta-Med, Llc | Needle cover assembly for a syringe |
| WO2010012650A1 (en) * | 2008-07-28 | 2010-02-04 | Syddansk Universitet | Compounds for the treatment of metabolic diseases |
| US8162882B2 (en) | 2010-06-23 | 2012-04-24 | Sta-Med, Llc | Automatic-locking safety needle covers and methods of use and manufacture |
| CA2825519A1 (en) | 2011-02-03 | 2012-09-08 | Lupin Limited | Pyrrole derivatives used as modulators of alpha7 nachr |
| WO2012166746A1 (en) | 2011-05-31 | 2012-12-06 | Sta-Med, Llc | Blood collection safety devices and methods of use and manufacture |
| EP2910549A1 (en) | 2011-09-15 | 2015-08-26 | Arizona Board of Regents, a Body Corporate of the State of Arizona acting for and on behalf of Arizona State University | 1,2,3,4-tetrahydro-1,1,4,4-tetramethylnaphthalene derivatives useful as rxr modulators for treating alzheimer's disease and cancer |
| US10328040B2 (en) | 2014-01-17 | 2019-06-25 | Arizona Board Of Regents On Behalf Of Arizona State University | Therapeutic methods |
| CN107176945B (zh) * | 2016-03-11 | 2021-06-08 | 中国科学院上海有机化学研究所 | 一种视黄酸类化合物、其制备方法、中间体及应用 |
| US10238626B2 (en) | 2017-01-23 | 2019-03-26 | Arizona Board Of Regents On Behalf Of Arizona State University | Therapeutic compounds |
| US10238655B2 (en) | 2017-01-23 | 2019-03-26 | Arizona Board Of Regents On Behalf Of Arizona State University | Dihydroindene and tetrahydronaphthalene compounds |
| US10231947B2 (en) | 2017-01-23 | 2019-03-19 | Arizona Board Of Regents On Behalf Of Arizona State University | Isochroman compounds and methods of use thereof |
Family Cites Families (89)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4326055A (en) | 1977-12-22 | 1982-04-20 | Hoffmann-La Roche Inc. | Stilbene derivatives |
| CH651034A5 (de) | 1982-05-12 | 1985-08-30 | Hoffmann La Roche | Chroman-, thiochroman- oder 1,2,3,4-tetrahydrochinolinderivate und ihre verwendung als arzneimittel-wirkstoffe. |
| DK158947C (da) | 1982-07-06 | 1991-01-21 | Hoffmann La Roche | Tetrahydronaphthalin-,benzofuran- og benzothiophenderivater, fremstilling og anvendelse deraf samt rodenticid indeholdende saadanne derivater |
| US4539154A (en) | 1983-06-15 | 1985-09-03 | Hoffmann-La Roche Inc. | Polyene compounds |
| EP0130795B1 (en) | 1983-07-05 | 1988-11-23 | Pfizer Inc. | Carboxylic acid derivatives useful for inhibiting the degradation of cartilage |
| WO1985000806A1 (en) | 1983-08-08 | 1985-02-28 | Sri International | Benzonorbornenyl, benzopyranyl and benzothiopyranyl retinoic acid analogues |
| FR2562539B1 (fr) | 1984-04-06 | 1987-04-17 | Chauvin Blache Lab | Nouveaux derives de l'acide vinyl-4 benzoique, leur procede de preparation et leurs applications en therapeutique et comme ligands |
| US4826984A (en) | 1984-04-09 | 1989-05-02 | The Board Of Regents For The Oklahoma Agricultural And Mechanical College Acting For And On Behalf Of Oklahoma State University | Heteroarotinoid compounds as anticancer agents |
| JPS6122046A (ja) | 1984-07-07 | 1986-01-30 | Koichi Shiyudo | スチルベン誘導体 |
| EP0170105B1 (en) | 1984-07-07 | 1990-10-17 | Koichi Prof. Dr. Shudo | Benzoic acid derivatives |
| LU85544A1 (fr) | 1984-09-19 | 1986-04-03 | Cird | Derives heterocycliques aromatiques,leur procede de preparation et leur application dans les domaines therapeutique et cosmetique |
| DE3434946A1 (de) | 1984-09-22 | 1986-04-03 | Basf Ag, 6700 Ludwigshafen | Diarylacetylene, ihre herstellung und verwendung |
| LU85849A1 (fr) | 1985-04-11 | 1986-11-05 | Cird | Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques |
| IL80270A0 (en) | 1985-10-11 | 1987-01-30 | Cird | Naphthalene derivatives,their preparation and pharmaceutical compositions containing them |
| DE3602473A1 (de) | 1986-01-28 | 1987-07-30 | Basf Ag | Vinylphenolderivate, ihre herstellung und verwendung |
| LU86351A1 (fr) | 1986-03-12 | 1987-11-11 | Oreal | Composes benzopyrannyl et benzothiopyrannyl benzoiques,leur procede de preparation et leur utilisation en cosmetique et en medecine humaine et veterinaire |
| DE3615157A1 (de) | 1986-05-05 | 1987-11-12 | Schwabe Willmar Gmbh & Co | 5-arylalkyl-4-alkoxy-2(5h)-furanone, zwischenprodukte und verfahren zu ihrer herstellung sowie ihre anwendung als therapeutische wirkstoffe |
| ZW6587A1 (en) | 1986-05-13 | 1987-12-02 | Hoffmann La Roche | Tetrahydro naphthanline derivatives |
| ZW7487A1 (en) | 1986-05-23 | 1987-12-16 | Hoffmann La Roche | Tetrahydronaphthaline and indane derivatives |
| ZW10287A1 (en) | 1986-07-15 | 1988-01-13 | Hoffmann La Roche | Tetrahydronaphthaline and indane derivatives |
| FR2601670B1 (fr) | 1986-07-17 | 1988-10-07 | Cird | Nouveaux derives bicycliques aromatiques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire et en cosmetique |
| US4739098A (en) | 1986-09-22 | 1988-04-19 | Allergan, Inc. | Ethynylphenyl-containing retinoic acid derivatives |
| US4923884A (en) | 1986-12-24 | 1990-05-08 | Allergan, Inc. | Ethynylheteroaromatic-acids having retinoic acid-like activity |
| US5149705A (en) | 1987-03-13 | 1992-09-22 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a tetralin group and having retinoid like activity |
| US5602130A (en) | 1987-03-20 | 1997-02-11 | Allergan | Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
| US5264578A (en) | 1987-03-20 | 1993-11-23 | Allergan, Inc. | Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| US5234926A (en) | 1987-03-20 | 1993-08-10 | Allergan, Inc. | Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
| US5089509A (en) | 1988-09-15 | 1992-02-18 | Allergan, Inc. | Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
| US4810804A (en) | 1987-03-26 | 1989-03-07 | Allergan, Inc. | Acetylenes disubstituted with a phenyl group and a heterobicyclic group having retinoid-like activity |
| IL85896A (en) | 1987-04-06 | 1993-01-14 | Riker Laboratories Inc | Substituted di-tert.- butylphenols and pharmaceutical compositions containing them |
| ZA885192B (en) | 1987-08-19 | 1989-04-26 | Hoffmann La Roche | Pharmaceutical preparations |
| KR0139216B1 (ko) | 1988-04-11 | 1998-05-01 | 제임스 엠. 캐내지 | 레티노이드 유사활성을 갖는 페놀 또는 벤조산의 테트랄린 에스테르 |
| US5015658A (en) | 1988-06-29 | 1991-05-14 | Allergan, Inc. | Thiochroman esters of phenols and terephthallates having retinoid-like activity |
| AU626881B2 (en) | 1988-07-14 | 1992-08-13 | F. Hoffmann-La Roche Ag | Benzofused heterocyclics used as pharmaceuticals |
| US4992468A (en) | 1989-07-26 | 1991-02-12 | Allergan, Inc. | Phenylethenyl compounds having retinoid-like activity |
| US5045551A (en) | 1989-09-19 | 1991-09-03 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| US5272156A (en) | 1989-09-19 | 1993-12-21 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| US5399561A (en) | 1989-09-19 | 1995-03-21 | Allergan, Inc. | Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydro-quinolinyl group having retinoid-like biological activity |
| US4980369A (en) | 1989-09-19 | 1990-12-25 | Allergan, Inc. | Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl or thiochromanyl group having retinoid-like activity |
| US5023341A (en) | 1989-09-19 | 1991-06-11 | Allergan, Inc. | Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
| US5013744B1 (en) | 1989-12-29 | 1994-09-20 | Allegran Inc | Acetylenes disubstituted with a pyridinyl group and a substituted phenyl group having retinoid like activity |
| US5006550A (en) | 1989-12-29 | 1991-04-09 | Allergan, Inc. | Chroman esters of phenols and benzoic acids having retinoid-like activity |
| US5202471A (en) | 1990-02-06 | 1993-04-13 | Allergan, Inc. | Alkyl, alkoxy and thioalkoxy substituted diphenyl acetylenes having retinoid like activity |
| WO1991016051A1 (en) | 1990-04-16 | 1991-10-31 | Rhône-Poulenc Rorer International (Holdings) Inc. | Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit egf receptor tyrosine kinase |
| LU87821A1 (fr) | 1990-10-12 | 1992-05-25 | Cird Galderma | Composes bi-aromatiques,et leur utilisation en medecine humaine et veterinaire et en cosmetique |
| US5563292A (en) | 1990-10-17 | 1996-10-08 | Schering Corporation | Lipoxygenase inhibitors |
| WO1992014725A1 (en) | 1991-02-13 | 1992-09-03 | Allergan, Inc. | Chroman and thiochromans with phenylethynyl substituents at the 7-position having retinoid-like biological activity |
| AU652830B2 (en) | 1991-03-26 | 1994-09-08 | Allergan, Inc. | Chromans and thiochromans with heteroarylethynyl substituents at the 7-position having retinoid-like biological activity |
| US5134159A (en) | 1991-03-26 | 1992-07-28 | Allergan, Inc. | 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
| FR2676440B1 (fr) | 1991-05-15 | 1993-07-30 | Cird Galderma | Nouveaux composes aromatiques derives d'imine, leur procede de preparation et leur utilisation en medecine humaine et veterinaire ainsi qu'en cosmetique. |
| EP0617614B1 (en) | 1991-12-18 | 1998-03-04 | The Salk Institute For Biological Studies | Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
| US5326898A (en) | 1992-02-11 | 1994-07-05 | Allergan, Inc. | Substituted phenylethenyl compounds having retinoid-like biological activity |
| WO1993016067A1 (en) | 1992-02-11 | 1993-08-19 | Allergan, Inc. | Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
| EP0617020A1 (en) | 1992-04-02 | 1994-09-28 | Shudo, Koichi, Prof. Dr. | Carboxylic acid derivatives having retinoic acid-like activity |
| JPH0672866A (ja) | 1992-07-02 | 1994-03-15 | Chugoku Igakuka Gakuin Yakubutsu Kenkyusho | 分化誘導剤 |
| US5466861A (en) | 1992-11-25 | 1995-11-14 | Sri International | Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors |
| DE69324043T2 (de) | 1993-01-11 | 1999-07-01 | Ligand Pharmaceuticals, Inc., San Diego, Calif. | Verbindungen mit selektiver wirkung fuer retinoid x rezeptoren, und mittel fuer steuerung fuer durch retinoid x rezeptoren bedingte prozesse |
| US5455265A (en) | 1993-02-11 | 1995-10-03 | Allergan, Inc. | Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors |
| EP0619116A3 (en) | 1993-04-05 | 1994-11-23 | Hoechst Japan | Use of synthetic retinoids for osteopathy. |
| US5426118A (en) | 1993-12-30 | 1995-06-20 | Allergan, Inc. | [4-(1,2-epoxycyclohexanyl)but-3-en-1-ynyl]aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity |
| CA2138000A1 (en) | 1994-01-03 | 1995-07-04 | John E. Starrett, Jr. | Retinoid-like compounds |
| CN1091092C (zh) | 1994-08-10 | 2002-09-18 | 霍夫曼-拉罗奇有限公司 | 视黄酸x－受体配位体、组合物及其用途 |
| US5534641A (en) | 1994-12-29 | 1996-07-09 | Allergan | Acetylenes disubstituted with 2-tetrahydropyranoxyaryl and aryl or heteroaryl groups having retinoid-like biological activity |
| US5498795A (en) | 1994-12-29 | 1996-03-12 | Allergan, Inc. | Acetylenes disubstituted with hydroxyaryl and aryl or heteroaryl groups having retinoid-like biological activity |
| US5599967A (en) | 1994-12-29 | 1997-02-04 | Allergan | Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity |
| US5648514A (en) | 1994-12-29 | 1997-07-15 | Allergan | Substituted acetylenes having retinoid-like biological activity |
| EP0800517A1 (en) * | 1994-12-29 | 1997-10-15 | Allergan | Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity |
| US5559248A (en) | 1995-04-05 | 1996-09-24 | Bristol-Myers Squibb Co. | Retinoid-like heterocycles |
| US6025388A (en) | 1995-04-26 | 2000-02-15 | Allergan Sales, Inc. | Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids |
| US5616712A (en) | 1995-05-16 | 1997-04-01 | Allergan | Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-thio-1,2,3,4-tetrahdroquinolinyl, 2-alkylthio-3,4-dihydroquinolinyl or 2-alkoxy-3,4-dihydroquinolinyl group having retinoid-like biological activity |
| US5952345A (en) | 1995-09-01 | 1999-09-14 | Allergan Sales, Inc. | Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| US5663357A (en) | 1995-11-22 | 1997-09-02 | Allergan | Substituted heteroarylamides having retinoid-like biological activity |
| US5675024A (en) | 1995-11-22 | 1997-10-07 | Allergan | Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity |
| US5688957A (en) | 1995-12-29 | 1997-11-18 | Allergan | (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity |
| US5965606A (en) | 1995-12-29 | 1999-10-12 | Allergan Sales, Inc. | Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity |
| US6063606A (en) * | 1996-06-21 | 2000-05-16 | Queen's University Kingston | Retinoid metabolizing protein |
| US5723666A (en) | 1996-06-21 | 1998-03-03 | Allergan | Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| US5773594A (en) | 1996-06-21 | 1998-06-30 | Allergan | Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| US5739338A (en) | 1996-11-05 | 1998-04-14 | Allergan | N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity |
| US6048873A (en) | 1998-10-01 | 2000-04-11 | Allergan Sales, Inc. | Tetrahdroquinolin-2-one 6 or 7-yl, tetrahdroquinilin-2-thione 6 or 7-yl pentadienoic acid and related derivatives having retinoid-like biological activity |
| US6369225B1 (en) * | 2000-08-29 | 2002-04-09 | Allergan Sales, Inc. | Compounds having activity as inhibitors of cytochrome P450RAI |
| US6313107B1 (en) * | 2000-08-29 | 2001-11-06 | Allergan Sales, Inc. | Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| US6291677B1 (en) | 2000-08-29 | 2001-09-18 | Allergan Sales, Inc. | Compounds having activity as inhibitors of cytochrome P450RAI |
| US6252090B1 (en) * | 2000-08-29 | 2001-06-26 | Allergan Sales, Inc. | Compounds having activity as inhibitors of cytochrome P450RAI |
| EP1366036B1 (en) | 2000-08-29 | 2006-01-11 | Allergan, Inc. | Compounds having activity as inhibitors of cytochrome p450rai |
| US6369261B1 (en) * | 2000-08-29 | 2002-04-09 | Allergan Sales, Inc. | Compounds having activity as inhibitors of cytochrome P450RAI |
| US6380256B1 (en) * | 2000-08-29 | 2002-04-30 | Allergan Sales, Inc. | Compounds having activity as inhibitors of cytochrome P450RAI |
| US6387951B1 (en) * | 2000-08-29 | 2002-05-14 | Allergan Sales, Inc. | Compounds having activity as inhibitors of cytochrome P450RAI |
| US6303785B1 (en) | 2000-08-29 | 2001-10-16 | Allergan Sales, Inc. | Compounds having activity as inhibitors of cytochrome P450RAI |
-
2000
- 2000-09-28 US US09/672,751 patent/US6313107B1/en not_active Expired - Fee Related
-
2001
- 2001-06-07 US US09/963,318 patent/US6495552B2/en not_active Expired - Fee Related
- 2001-06-07 US US09/875,967 patent/US6387892B1/en not_active Expired - Fee Related
- 2001-08-14 WO PCT/US2001/025465 patent/WO2002026727A2/en not_active Ceased
- 2001-08-14 JP JP2002531111A patent/JP2004509955A/ja active Pending
- 2001-08-14 CA CA002423919A patent/CA2423919A1/en not_active Abandoned
- 2001-08-14 AU AU8647801A patent/AU8647801A/xx active Pending
- 2001-08-14 EP EP01965927A patent/EP1322631A2/en not_active Withdrawn
- 2001-08-14 AU AU2001286478A patent/AU2001286478B2/en not_active Ceased
-
2002
- 2002-08-05 US US10/212,533 patent/US6855512B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004507531A5 (OSRAM) | ||
| ATE509935T1 (de) | Mischungen aus mono-carboxylfunktionalisierten dialkylphosphinsäuren, ein verfahren zu ihrer herstellung und ihre verwendung | |
| AU2003264698B2 (en) | Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof | |
| JP2001520304A5 (OSRAM) | ||
| JP2010528089A5 (OSRAM) | ||
| DE50212650D1 (de) | Verfahren zur herstellung von scopinestern | |
| DE502007006344D1 (de) | Mischungen aus Mono-Carboxyl funktionalisierten Dialkylphosphinsäureestern und weiteren Komponenten | |
| JP2003532752A5 (OSRAM) | ||
| JPH07503959A (ja) | レチノイド様生物学的活性を有するヘテロアリール置換フェニルエテニル化合物 | |
| NZ566788A (en) | Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammation | |
| JP2004520302A5 (OSRAM) | ||
| KR20030005417A (ko) | 치환된 벤조산 유도체를 유효 성분으로서 함유하는ＮＦ-κＢ 저해제 | |
| AR045800A1 (es) | Composicion catalizadora de auto - extincion con donador interno de ester de acido monocarboxilico y proceso de polimerizacion de propileno | |
| AU662379B2 (en) | Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase | |
| PL362366A1 (en) | New method of industrial synthesis of tetra esters of 5-[bis(carboxyl methyl)amino]-3 -karboxymethyl-4-cyano-2-tio phenokarboxylic acid, method of manufacture of divalent salts of ranelic acid and their hydrates, as well as new intermediate compounds | |
| JP2001181252A (ja) | ビニル化合物中のｎ−オキシル化合物の安定化方法 | |
| JP2007536285A5 (OSRAM) | ||
| WO2006103274A8 (fr) | Inhibiteurs d'age | |
| GB1291386A (en) | Improvements in or relating to 2-(6'-substituted-2'-naphthyl) propionic acid derivatives and salts thereof | |
| JP2010533707A5 (OSRAM) | ||
| DE602005008090D1 (de) | Verbessertes verfahren zur herstellung eines (meth)acrylanhydrids | |
| US5352701A (en) | Leukotriene-B4 antagonist compounds and their use as pharmaceutical agents | |
| IE913214A1 (en) | Pyridylthio or pyridyloxy alkanoic acids | |
| JP2007536240A5 (OSRAM) | ||
| Kopka et al. | Substituted N-(3, 5-dichlorobenzenesulfonyl)-L-prolyl-phenylalanine analogues as potent VLA-4 antagonists |